Diagnostic values of glycated haemoglobin and diagnosis of diabetes: Results of a cross-sectional survey among general practitioners in the province of Reggio Emilia, Italy  by Ballotari, Paola et al.
Original Research
Diagnostic values of glycated haemoglobin and diagnosis of diabetes:
Results of a cross-sectional survey among general practitioners in the
province of Reggio Emilia, Italy
Paola Ballotari a,b,*, Francesca Roncaglia a, Soﬁa Chiatamone Ranieri c, Marina Greci d,
Valeria Manicardi e, Paolo Giorgi Rossi a,b
a Servizio Interaziendale di Epidemiologia, Local Health Authority of Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy
b IRCCS, Arcispedale Santa Maria Nuova, Viale Umberto I 50, 42123 Reggio Emilia, Italy
c Clinical Pathology and Microbiology Laboratory, Department of Laboratory Medicine, G. Mazzini Hospital, Local Health Authority of Teramo, Piazza Italia,
64100 Teramo, Italy
d Primary Health Care Department, Local Health Authority of Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy
e Department of Internal Medicine, Hospital of Montecchio, Local Health Authority of Reggio Emilia, Via Barilla 16, 42027 Montecchio, Italy
A R T I C L E I N F O
Article history:
Received 17 September 2015
Received in revised form 27 December
2015
Accepted 6 January 2016
Keywords
Glycated haemoglobin
Diabetes diagnosis
General practitioner
Diabetes register
Multilevel analysis
A B S T R A C T
Aims: The aim of this study was to investigate whether subjects included in the diabetes register solely
because their HbA1c was over the diagnostic threshold received a diagnosis of diabetes from their general
practitioner (GP).
Methods: The study included all registered cases in 2009–2010 aged 18 or over that were identiﬁed only
by the laboratory database because they had one or more HbA1c over the 6.5% threshold and for whom
we did not ﬁnd any information in the search of full electronic clinical records. Multilevel logistic re-
gression was used to examine the inﬂuence of GP and patient characteristics.
Results: There were 228 participating GPs (76.3% of those invited) and 832 assessed subjects (68.8% of
study population). There was a strong clustering among the GPs (residual intraclass correlation = 0.52,
95% CI 0.40–0.64). About one in two (55.5%) subjects with two or more HbA1c > =6.5% has been diag-
nosed as diabetic and the percentage declined – unless zeroing – in case the abnormal value was only
one (28.3%). The likelihood of being labelled ‘no diabetes’ was greater in subjects aged less than 65 or
over 74 with respect to the reference age group (OR 1.89, 95% CI 1.13–3.15; OR 1.55 95% CI 0.94–2.53).
The same likelihood consistently decreased when HbA1c test was accompanied by abnormal fasting plasma
glucose (FPG) assay (OR 0.20, 95% CI 0.12–0.32).
Conclusions: A permanent exchange of information between the diabetes register and GPs should bemain-
tained to improve the care of patients and the awareness of criteria for diabetes diagnosis among GPs.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
The onset of type 2 diabetes (T2DM) is slow, and the disease is
often asymptomatic for a long time, as glucose levels increase only
gradually over time. Diabetesmay remain undetected formany years,
thus leading to severe complications [1–4]. Therefore, diabetes must
be diagnosed as early as possible, so that appropriate action can be
taken to prevent or delay the development of complications. In 2011,
a high level of glycated haemoglobin (HbA1c) was endorsed by the
World Health Organisation (WHO) as a suﬃcient criterion for T2DM
using a diagnosis threshold of ≥ 6.5% (48 mmol/mol) [5]. The WHO
states that diagnosis can be based on either glucose tests or HbA1c,
although in asymptomatic patients, elevated HbA1c or fasting glucose
should be conﬁrmed by repeating the same test [6].
The utility of HbA1c in diabetes screening is under discussion
[7], especially because of its low sensitivity (42–44%), although its
speciﬁcity is 99.6% [8].
Despite its low sensitivity, a threshold of 6.5% for HbA1c
(48 mmol/mol) has a strong clinical rationale, since this is the level
at which the risk of complications has been shown to rise and,
indeed, at which measures should be taken to control glycaemia [6].
Given these considerations, the diabetes register for the prov-
ince of Reggio Emilia includes the HbA1c measurement database
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among the sources, using ‘having at least one HbA1c value of ≥ 6.5%
(48 mmol/mol) as an inclusion criterion’ [9].
The aim of this study was to investigate whether the subjects
included in the diabetes register solely because they have an HbA1c
over the threshold did in fact receive a diagnosis of diabetes from
their general practitioner (GP).
Material and methods
Setting
The diabetes register catchment area is the province of Reggio
Emilia, which is situated in Northern Italy and has a population of
approx. 550,000. It includes all resident patients who are identi-
ﬁed by one or more of the following sources: hospital discharge,
drug dispensation, HbA1c values from the biochemistry laborato-
ry, disease-speciﬁc exemption, diabetes outpatient clinics, and
mortality databases [9]. Women with gestational diabetes or who
were receiving treatment for polycystic ovarian syndrome are ex-
cluded from the register. Furthermore, the applied algorithm is able
to ascertain cases and to distinguish types of diabetes and care set-
tings. Currently, the diabetes register contains both incident and
prevalent cases of diabetes from 2009 to 2013.
For patients identiﬁed by one or more sources that do not specify
the type of diabetes, full electronic clinical records are searched to
complete the records. As per other disease registers based on rou-
tinely collected databases, the data collection and search in the
electronic clinical record are delayed with respect to the reference
period, and for the 2009–2010 data, both procedures were carried
out during 2013. Once the uploading process is ﬁnished, a small
group of subjects belongs to the register solely because they have
of one or more HbA1c values over the threshold; these subjects are
the population included in this study.
In accordancewith regional guidelines [10], patients ﬁrst see their
GP and, if diabetes is suspect on the strength of glycaemic tests, they
should be referred by the GP to diabetes clinics (DCs) to conﬁrm
the diagnosis and stage their diabetes. The patients included in this
study were unknown to the DCs; therefore, they were not re-
ferred to specialised clinics for the initial assessment and are not
included in any structured diagnostic and therapeutic pathway. Pos-
sibly, they could be diagnosed as T2DM and cared exclusively for
by their GP through diet and lifestyle advice, or they could be un-
diagnosed or they could have one abnormal HbA1c value due to
being affected by pre-diabetes or by one of other conditions arti-
ﬁcially increasing HbA1c values, carbamylated haemoglobin (renal
failure), hypertriglyceridaemia, hyperbilirubinaemia, or iron deﬁ-
ciency [6,11].
To better understand if these subjects were diagnosed as having
diabetes or not, and if not why, a survey of GPs was carried out.
Study design
This was a cross-sectional study conducted by surveying GPs. The
study included all registered cases in 2009–2010 aged 18 or over
that were identiﬁed only by the laboratory database because they
had one or more HbA1c over the 6.5% threshold and for whom we
did not ﬁnd any information in the search of full electronic clini-
cal records (Fig. 1). For this group of cases, there is no mention of
diabetes anywhere in the available electronic sources; therefore, to
know if they received a diagnosis or not we had to ask to their GPs.
Each GP received a list of his/her patients showing the date(s)
and the value(s) of HbA1c assay(s), along with additional informa-
tion about the fasting plasma glucose (FPG) assay, if this test was
performed. The surveywas conducted in the ﬁrst sixmonths of 2014;
hence, allowing the GP to answer according to the medical charts
updates in 2014.
Outcome and covariates
The outcome of interest was conﬁrmation of diabetes diagno-
sis by the GP (yes or no).
Independent variables included in the analyses are listed below:
GP level: sex, age (years).
Patient level: sex, age (years), foreign status (determined as per
citizenship), ﬁrst HbA1c value equal or over the threshold, number
of HbA1c assays, value of FPG closest to ﬁrst diagnostic HbA1c,
all measures performed in 2009–2010. Additionally, for pa-
tients with only one HbA1c value over the threshold in the
reference period, we retrieved information about further HbA1c
tests done in 2011–2013, and we classiﬁed this variable in three
categories: “further HbA1c > = 6.5% in 2011–13”; “further HbA1c
<6.5% in 2011–13”; “not retested in 2011–13”.
Statistical methods
We compared the demographic and clinical characteristics of the
study population, stratiﬁed based on whether the GP answered or
not. Afterwards, the subjects for whom a responsewas obtainedwere
stratiﬁed by type of response. Chi square tests were performed to
highlight possible differences in the probability to be assessed and
to be diagnosed among the different categories of each of the con-
sidered variables.
Multilevel logistic regression was used to examine the inﬂu-
ence of GP (level 2) and patient (level 1) characteristics on GP
diagnosis in the assessed patients and separately in subjects with
two or more HbA1c and in those not retested. The ﬁxed effects are
presented as odds ratios (ORs) with 95% conﬁdence intervals (95%
only HbA1c>=6.5%
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Figure 1. Study population selection ﬂow.
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CI). An intra-GP intraclass correlation coeﬃcient (ICC) was calcu-
lated. Analyses were carried out using the STATA statistical package,
Version 11.
Ethical approval
The diabetes register was approved by the provincial Ethics Com-
mittee in July 2014. Direct contact with GPs to conﬁrm information
from register data sources was included in the protocols for regis-
tration approved by the Ethics Committee. According to the Italian
privacy law, no patient or parental consent is required for large ret-
rospective population-based studies approved by an Ethics
Committee when data are published in aggregate form only.
Results
At the end of 2010, there were 27,525 residents aged 18 or over
included in the diabetes register (6.3% of the general population),
of whom 2684 (9.8%) were acquired solely by the HbA1c criterion
(Fig. 1). For 1474 patients, we found a T2DM diagnosis in supple-
mentary sources, along with discharge and medical reports; thus,
the remaining 1210 subjects (4.3% of the population included in the
register) comprised the target population of this study.
Out of the 299 GPs invited, 228 (76.3%) participated. There was
no difference in sex or age between participating and non-
participating GPs (p = 0.380 and p = 0.331, respectively).
Among surveyed subjects (Table 1), 265 (21.9%) were not inves-
tigated because the GP did not participate, and 113 (9.3%) were not
assessed by the GP (i.e. missing) because the subjects were de-
ceased (62) or had emigrated (14), or the GP simply did not evaluate
that patient (37).
Comparing not investigated vs. assessed subjects, the former
seemed to have higher HbA1c and FPG values (% of having
HbA1c > =7%: 35.5% vs 25.1, p = 0.004; % of having FPG > =126mg/dL:
43.4% vs 31.7%, p = 0.001). Moreover, the percentage of not re-
tested was higher in not investigated patients with respect to the
assessed (48.5% vs 40.0%, p = 0.020).
When missing vs. assessed subjects were compared, the former
seemed to be older (% aged 75+ : 60.2 vs 34.7, p < 0.001) and were
more likely not to be retested during 2011–2013 (62.4% vs 40.0,
p < 0.001).
More than half of the assessed patients (461/832 = 55.4%) had
two or more HbA1c values > = 6.5% (i.e. for 185 the two values were
obtained in the study period and for 276 the second one was ob-
tained during 2011–2013). One in three (259/832 = 31.1%) had only
one HbA1c value over the 6.5% threshold during the study period
and they were not retested in 2011–2013 and the remaining (112/
832 = 13.5%) had only one HbA1c value in > = 6.5% followed by further
values in 2011–2013 below the threshold. In each of the above-
mentioned groups, we found patients diagnosed as diabetic and
patients who were not, although with different percentages.
When the whole study population was analysed, the intra-
class correlation (Table 2) showed a strong clustering among the
GPs, with almost 50% of total variance accounted for by the GP clus-
tering. The likelihood of having a ‘no DM’ label was higher in subjects
aged less than 65 or over 74, with respect to the reference age group
(65–74 years), and in people who are not conﬁrmed diabetics, either
without any repeated test or with a repeated test below the diag-
nostic threshold, compared to those having at least two abnormal
results. Conversely, the likelihood of having a ‘no DM’ label signiﬁ-
cantly decreased when the HbA1c test was associated with FPG
values > = 126 mg/dL.
When we restricted the analysis to subjects with two or more
HbA1c values over the 6.5% threshold (Table 3), the residual intraclass
correlation has lower than in the overall population. The risk to be
undiagnosedwas double for those aged below 65 and seemed higher
also for those aged over 74. Conversely, the risk was very low when
the glycaemia alteration was conﬁrmed by the FPG test.
Table 1
Demographic and clinical characteristics of study population
Characteristics Diagnosed as DM
(n = 361)
Not diagnosed as DM
(n = 471)
p Assessed
(n = 832)
Missinga
(n = 113)
Not investigatedb
(n = 265)
Sex: n(%) 0.127
Males 174 (46.3) 202 (53.7) 376 68 133
Females 187 (41.0) 269 (59.0) 456 45 132
Age groups: n (%) 0.089
<35 2 (66.7) 1 (33.3) 3 - -
35–44 7 (30.4) 16 (69.6) 23 - 11
45–54 32 (38.1) 52 (61.9) 84 11 25
55–64 70 (42.2) 96 (57.8) 166 9 51
65–74 134 (50.2) 133 (49.8) 267 25 65
75 + 116 (40.1) 173 (59.9) 289 68 113
Citizenship: n (%) 0.258
Italian 351 (43.8) 451 (56.2) 802 109 252
Foreign 10 (33.3) 20 (66.7) 30 4 13
HbA1c value: n (%) <0.001
48 mmol/mol (6.5%) 65 (30.2) 150 (69.8) 215 21 55
49–52 mmol/mol (6.6%–6.9%) 184 (45.1) 224 (54.9) 408 58 116
53 + mmol/mol (7 + %) 112 (53.6) 97 (46.4) 209 34 94
# HbA1c test: n (%) <0.001
2 or more 101 (54.6) 84 (45.4) 185 20 59
Only 1 260 (40.2) 387 (59.8) 647 93 206
Further HbA1c > = 6.5% in 2011–13 155 (56.2) 121 (43.8) 276 26 85
Further HbA1c <6.5% in 2011–13 25 (22.3) 87 (77.7) 112 9 21
Not tested in 2011–13 80 (30.9) 179 (69.1) 259 58 100
FPG value: n (%) <0.001
<126 mg/dL 192 (33.8) 376 (66.2) 568 77 150
> = 126 mg/dL 169 (64.0) 95 (36.0) 264 36 115
a Patients for whom the participating GP not provided a response.
b Patients assigned to not participating GP.
23P. Ballotari et al. / Journal of Clinical & Translational Endocrinology 3 (2016) 21–25
In the group composed by subjects with only one HbA1c value
over the threshold in 2009–2010 and not retested during the
subsequent period, the likelihood to be labelled as “no diabetes”
was inversely associated with higher HbA1c values and to the pres-
ence of a diagnostic FPG value.
Discussion
The number of subjects included in the diabetes register solely
on the basis of diagnostic HbA1c test was quite small (4.3% of sub-
jects with diabetes and 0.3% of the resident population aged 18 or
over). Our results are consistent with those of a similar study [12]
andmay reﬂect the ability of the health system to direct people with
diabetes diagnosed by HbA1c into an appropriate care model that
includes specialised visits, medication (if needed) and/or exemp-
tion from costs related to the disease.
Nevertheless, the survey suggests that feedback to the GP may
be an effective tool for improving the timeliness of diabetes diag-
nosis and at the same time to develop proactive medical initiatives.
In fact, almost 45% of subjects with two or more HbA1c values over
the threshold, i.e. with suﬃcient and very speciﬁc criteria to be di-
agnosed as diabetic, were not referred to DC or diagnosed as diabetes
cases. Additionally, almost one in ten was not retested, while the
guidelines recommend repeating the test in the event of one ab-
normal HbA1c value. Finally, one in four apparently with no diabetes
because the second test was below the cut-off has been diagnosed
as suffering from diabetes.
The multilevel analysis showed a strong GP clustering effect,
which means that the latent characteristics of the practitioner
other than those taken into account play a role in diagnostic
decision-making process. This result, combined with the presence
of undiagnosed and diagnosed among those not totally fulﬁlling the
WHO criterion, suggests a lack of uniformity in the application of
the guidelines.
People aged over 74 were more likely to be considered as ‘not
having diabetes’ than those included in the reference class, which
is consistent with several studies that call attention to increases in
physiological HbA1c with ageing [13–16]. However, even subjects
aged below 65 had a higher likelihood; in this case, the GP would
have preferred a disglycaemia as the diagnosis. These two ﬁnd-
ings suggest that two different conditions may favour an absence
of diabetes diagnosis: newly acquired diabetes in younger and older
people who may be underserved or institutionalised. The latter
usually lose contact with their GPs and have poor access to hospi-
tal or outpatient care.
Foreign status was not associated with undiagnosed diabetes,
as some authors have found [17–19], although the small number
of foreigners does not provide a suﬃciently large statistical sample
to exclude minor differences.
Furthermore, the reduced likelihood to be considered as ‘not
having diabetes’ in presence of diagnostic FPG suggests an attitude
Table 2
Odds ratios (OR) for subjects no diagnosed as DM vs diagnosed as DM and 95% con-
ﬁdence intervals (95% CI), patients and GP variables, whole study population
Variables OR 95%CI
Individual level
Sex
Male 1
Female 1.10 0.73–1.66
Age groupa (years):
<65 1.89 1.13–3.15
65–74 1
75 + 1.55 0.94–2.53
Foreign status
Italian 1
Foreign 0.80 0.24–2.63
HbA1c value (%):
48 mmol/mol (6.5%) 1
49–52 mmol/mol (6.6%–6.9%) 0.61 0.37–1.00
53 + mmol/mol (7 + %) 0.61 0.33–1.14
# HbA1c test
2 or more in 2009–2013b > =6.5% 1
Only 1 > =6.5% in 2009–10 repeated in
2011–13, but < 6.5%
5.73 2.91–11.30
Only 1 > =6.5% in 2009–10 not retested
in 2011–13
4.43 2.68–7.32
FPG value (mg/dL)
<126 1
> = 126 0.20 0.12–0.32
GP level
Sex
Male 1
Female 1.19 0.54–2.63
Age group (years)
<55 1
55 + 0.54 0.25–1.11
Residual intraclass correlation 0.52 0.40–0.64
LR test vs. logistic regression p < 0.001.
a Subjects aged below 65 years were grouped in the same class.
b This class includes subjects with 2 or more HbA1c > =6.5% in 2009–2010 (n = 185)
and those with only one HbA1c > =6.5% in 2009–2010, but with further HbA1c in
2011–2013 (276).
Table 3
Odds ratios (OR) for subjects no diagnosed as DM vs diagnosed as DM and 95% con-
ﬁdence intervals (95% CI), patients and GP variables, by number and type of HbA1c
valuesa
2 + HbA1c > = 6.5
(n = 461)b
Only 1 > =6.5%
not retested (n = 259)
Variables OR 95% CI OR 95% CI
Individual level
Sex
Male 1 1
Female 0.82 0.49–1.38 1.10 0.47–2.60
Age groupc (years)
<65 2.03 1.06–3.90 2.12 0.70–6.41
65–74 1 1
75 + 1.42 0.77–2.59 1.84 0.64–5.30
Foreign status
Italian 1 1
Foreign 2.63 0.27–25.74 0.45 0.07–2.94
HbA1c value (%)
48 mmol/mol (6.5%) 1 1
49–52 mmol/mol (6.6%–6.9%) 0.74 0.38–1.43 0.28 0.10–0.81
53 + mmol/mol (7 + %) 0.98 0.45–2.13 0.17 0.04–0.61
FPG value (mg/dL)
<126 1 1
> = 126 0.19 0.10–0.35 0.24 0.08–0.66
GP level
Sex
Male 1 1
Female 1.24 0.53–2.88 1.29 0.37–4.48
Age group (years)
<55 1 1
55 + 0.80 0.37–1.73 0.34 0.11–1.07
Residual intraclass correlation 0.44 0.27–0.63 0.53 0.28–0.77
LR test vs. logistic regression p < 0.001, p = < 0.001, respectively.
a Due to a small number of patients with only one HbA1c > = 6.5% (n = 112), the
multilevel logistic regression was not computable.
b This class includes subjects with 2 or more HbA1c > =6.5% in 2009–2010 (n = 185)
and those with only one HbA1c > =6.5% in 2009–2010, but further HbA1c in 2011–
2013 (276).
c Subjects aged below 65 years were grouped in the same class.
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of traditional glucose criteria or at least of combining the two tests
(i.e. HbA1c and FPG tests).
Strengths and limitations
This study accounts for physician-level variation by multilevel
modelling and covers the entire province. Furthermore, overall
participation was quite high compared with other physician surveys
[20–22]
Themain limitation was the lack of information on patient symp-
toms and comorbidities that artiﬁcially increases HbA1c values.
Additionally, the results could be affected by attrition bias, because
older subjects dropped out of the studymore frequently than others
and were considered at higher risk of having undetected diabetes
in an advanced age. In the target population, the proportion of sub-
jects with a recognised diagnosis of diabetes by the GPmay be lower
than that found in the study population.
Finally, our survey may have been inﬂuenced both by GP aware-
ness on diabetes achieved using the medical ﬁles up to 2014 and
by a degree of desirability bias in answers; i.e. the diagnosis could
be induced, consciously or not, by our survey. Nevertheless, a con-
sistent number of patients are still undiagnosed.
Conclusion
The linkage of multiple electronic sources for compiling the di-
abetes register yielded only a small number of subjects with a sole
diagnostic HbA1c value alone – a sign that the health care system
detects diabetic subjects at an early stage. Nevertheless, certain
actions should be planned, such as establishing a permanent ex-
change of information between GPs and the diabetes register, as well
as further dissemination of the criteria used for diabetes diagno-
sis, particularly regarding the use of HbA1c as a diagnostic tool with
high speciﬁcity.
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